Over the past few decades, interest in biomarkers to enhance predictive modeling has soared. Methodology for evaluating these has also been an active area of research. There are now several performance measures available for quantifying the added value of biomarkers. This commentary provides an overview of methods currently used to evaluate new biomarkers, describes their strengths and limitations, and offers some suggestions on their use.
CITATION STYLE
Cook, N. R. (2018). Quantifying the added value of new biomarkers: how and how not. Diagnostic and Prognostic Research, 2(1). https://doi.org/10.1186/s41512-018-0037-2
Mendeley helps you to discover research relevant for your work.